T. Rowe Price Associates’s IES Holdings IESC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$37.5M Sell
102,220
-22,252
-18% -$7.18M ﹤0.01% 971
2026
Q1
$29.7M Buy
124,472
+2,830
+2% +$649K ﹤0.01% 934
2025
Q4
$23.7M Buy
121,642
+2,598
+2% +$522K ﹤0.01% 1022
2025
Q3
$23.7M Buy
119,044
+2,106
+2% +$362K ﹤0.01% 1022
2025
Q2
$17.3M Buy
116,938
+1,982
+2% +$234K ﹤0.01% 987
2025
Q1
$9.49M Buy
114,956
+108,360
+1,643% +$11.3M ﹤0.01% 1122
2024
Q4
$663K Buy
6,596
+1,140
+21% +$137K ﹤0.01% 2162
2024
Q3
$545K Buy
5,456
+156
+3% +$12.6K ﹤0.01% 2210
2024
Q2
$370K Buy
5,300
+606
+13% +$42.6K ﹤0.01% 2314
2024
Q1
$286K Buy
+4,694
New +$225K ﹤0.01% 2454
2022
Q2
Sell
-10,504
Closed -$211K 2983
2022
Q1
$211K Buy
10,504
+304
+3% +$6.86K ﹤0.01% 2695
2021
Q4
$258K Buy
+10,200
New +$255K ﹤0.01% 2659
2021
Q3
Sell
-7,800
Closed -$200K 2960
2021
Q2
$200K Buy
+7,800
New +$202K ﹤0.01% 2732
2021
Q1
Sell
-9,156
Closed -$211K 2856
2020
Q4
$211K Buy
+9,156
New +$179K ﹤0.01% 2541

Other funds holding IESC

T. Rowe Price Associates's IESC Position: Q2 2026 in Review

T. Rowe Price Associates reduced its IES Holdings (IESC) stake by 18% in Q2 2026, selling an estimated $7.18M and leaving 102,220 shares worth $37.5M. The position accounts for ﹤0.01% of the portfolio, ranked #971.

T. Rowe Price Associates first reported a position in IESC in Q4 2020 and has held it in 14 quarters since. 413 funds tracked by Wall St. Rank hold IESC as of Q2 2026.

  • T. Rowe Price Associates held 102,220 shares of IES Holdings worth $37.5M as of Q2 2026.
  • T. Rowe Price Associates sold 22,252 IES Holdings shares in Q2 2026, an estimated $7.18M.
  • IES Holdings made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q2 2026, its #971 holding.
  • T. Rowe Price Associates first reported a position in IES Holdings in Q4 2020 and has held it in 14 quarters since.
  • 413 funds tracked by Wall St. Rank held IES Holdings as of Q2 2026.

Based on T. Rowe Price Associates's 13F filing for Q2 2026, filed 14 Aug 2026.